Typically, all above genes are recurrently altered in meningiomas across all WHO grades, despite controversial results have been reported about a greater frequency of the NF2, KLF4, and SMO gene variants in WHO grade 2/3 vs WHO grade 1 meningiomas (12, 15). This evidence concerns the gene KLF4 and meningioma.